Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Apr 20, 2021 12:58pm
321 Views
Post# 33029854

Drought is over, turn around day

Drought is over, turn around day

After a pre- announcement run up, The price as we know dropped off daily.
I know a few people who are T.A traders predcting we are close to or even past the recent bottom.
further evidence, most broad markets are down today. Onc is boarder line  up & down.
Showing some good late am recovery.
fundamentals?
never been better. I expect to hear about a car- T partnership. My guess before end of this year.
the aware-1, did meet endpoints. However Pfizer has a first right of refusal,& that comes into play pending bracelet study.
THAT is what killed the price. Not bad news, but again, more time needed.
the Car-t deal will come out of the blue. Surprise everyone. It also will be a long timeline, but if promoted correctly, will boost price & credibility.
without pending, " news" the price is victim to trading, shorting etc.
long term?
look at the 9 month chart
the lows keep getting higher.
 

<< Previous
Bullboard Posts
Next >>